Skip to content

News archive

  • Cermaq terminates purchased farming permits

    Cermaq terminates purchased farming permits. When the proposal for resource rent tax for aquaculture was presented, the authorities opened for returning permits purchased at fixed prices in 2022. Cermaq therefore terminates the purchase of 669 tons MAB at a value of NOK 134 million.

  • Sea the Solution

    The use of the ocean by many industries has not sufficiently respected the multiple roles and complex biodiversity in the ocean, Cermaq recognizes in launching Sea the Solution. As research unfolds fact and casual relationships, we are better positioned to move from harm to harmony. And we must all take part.

  • Has Covid permanently lifted salmon demand?

    Consumers seem to have embraced salmon as a convenient and healthy food for home preparation. The strong rise in home consumption of salmon was a response to the restrictions or close-down of restaurant and outdoor dining. Now as society opens up the retail sales remains high.

  • The first iFarm fish on the way to market

    The results from the harvest show high quality of the iFarm fish, which confirms that the health and welfare of the fish has been good in the iFarm net pens. The very first iFarm fish was stocked in Martnesvika sea site in the autumn of 2020.

  • Cermaq Chile announces new Managing Director

    With more than 20 years of experience in the industry, Pedro Courard, current Production Director of the company, becomes the new Managing Director of Cermaq Chile. He replaces Steven Rafferty who becomes the new CEO of Cermaq Group, based in Oslo, Norway, starting 1 March 2022.
    Pedro is an industrial civil engineer from the University of Chile and has an MBA from the University of Tulane, USA

  • Benchmark Animal Health and Cermaq receive funding from the Research Council of Norway for the development of Tenacibaculum vaccines for salmon

    Mouth rot and tenacibaculosis represent a major issue for the health and welfare in farmed Atlantic salmon
    Benchmark Animal Health, a leading aquaculture biotechnology company, and Cermaq Group AS, a world leading salmon farming company, announced receipt of NOK 4.2 million in funding from the  Research Council of Norway, to support a collaborative research project to develop a vaccine against

  • The iFarm project aims to improve fish welfare with AI and machine learning – Now an entire sea site is equipped with iFarm setup for the first time

    The iFarm project, which has been ongoing since January last year, is in its second phase. An entire sea site in Vesterålen, Norway is now equipped with an iFarm setup in all the net pens, after the fish was stocked there this autumn. The goal is to increase fish health and welfare with artificial intelligence and machine learning.

Show more